A20

B cell lymphoma cell line derived from a spontaneous reticulum cell neoplasm in BALB/c mouse.
Cell Type:
B cell
Tissue Origin:
blood
Species:
mouse
Research Area:
Cancer Research/Cell Biology
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
SF FF-113 4e5 98% 70-76% Plasmid (general) 0.4 µg 20 µl 4D X-Unit
SF FF-113 2e6 98% 65-67% Plasmid (general) 2 µg 100 µl 4D X-Unit
V L-013 2e6 63-85% 72-90% Plasmid (general) 2 µg 100 µl I/II/2b
SF FF-150 4e6 80% good Plasmid (general) 2 µg 20 µl 96-well
SF FF-120 4e6 80% good Plasmid (general) 2 µg 20 µl 96-well

Citations

Categories:
Transfection 
Authors:
Onabajo OO, Seeley MK, Kale A, Qualmann B, Kessels M, Han J, Tan TH, Song W 
In:
J Immunol (2008) 180(10): 6685-95 
Categories:
Transfection 
Authors:
Siegel AM, Herskowitz JH, Speck SH 
In:
PLoS Pathog (2008) 4(4): e1000039 
Categories:
Transfection 
Authors:
Lin KB, Freeman SA, Zabetian S, Brugger H, Weber M, Lei V, Dang-Lawson M, Tse KW, Santamaria R, Batista FD, Gold MR 
In:
Immunity (2008) 28(1): 75-87